Canada markets closed

Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7000+0.0500 (+3.03%)
At close: 04:00PM EDT
1.7000 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 233.90M
Enterprise Value 83.17M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.57
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.72

Trading Information

Stock Price History

Beta (5Y Monthly) 0.60
52-Week Change 3-52.59%
S&P500 52-Week Change 322.38%
52 Week High 33.6200
52 Week Low 31.1500
50-Day Moving Average 31.7990
200-Day Moving Average 31.8794

Share Statistics

Avg Vol (3 month) 3371.17k
Avg Vol (10 day) 3202.68k
Shares Outstanding 5137.59M
Implied Shares Outstanding 6137.59M
Float 8102.85M
% Held by Insiders 113.44%
% Held by Institutions 162.89%
Shares Short (Apr 15, 2024) 41.62M
Short Ratio (Apr 15, 2024) 43.95
Short % of Float (Apr 15, 2024) 41.66%
Short % of Shares Outstanding (Apr 15, 2024) 41.18%
Shares Short (prior month Mar 15, 2024) 41.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-17.66%
Return on Equity (ttm)-25.74%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -49.66M
Net Income Avi to Common (ttm)-42.49M
Diluted EPS (ttm)-0.3300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)152.46M
Total Cash Per Share (mrq)1.11
Total Debt (mrq)1.73M
Total Debt/Equity (mrq)1.17%
Current Ratio (mrq)19.73
Book Value Per Share (mrq)1.16

Cash Flow Statement

Operating Cash Flow (ttm)-40.62M
Levered Free Cash Flow (ttm)-25.2M